NMTR

9 Meters Biopharma (NMTR)

9 Meters Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NMTR

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/07/22	05 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/07/18	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/05/19	21 : 08	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/05/16	06 : 28	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/05/16	06 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/04/27	21 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/04/07	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/04/05	21 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/04/01	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/04/01	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/30	05 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/30	05 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/28	21 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/16	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/15	20 : 40	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/14	03 : 42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/03/13	21 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2023/02/10	01 : 59	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/11/11	00 : 10	TipRanks	Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), 9 Meters Biopharma (NMTR) and Graphite Bio (GRPH)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/11/10	00 : 25	TipRanks	Maxim Group Remains a Hold on 9 Meters Biopharma (NMTR)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/11/02	05 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/10/22	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/10/17	21 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/10/07	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/09/30	05 : 17	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/09/30	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/09/29	22 : 35	TipRanks	9 Meters Biopharma (NMTR) Receives a Buy from BMO Capital	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/09/27	23 : 10	AllPennyStocks.com	Biotech Attracts Significant Premarket Buying Pressure	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/08/17	04 : 55	TipRanks	Maxim Group Keeps Their Hold Rating on 9 Meters Biopharma (NMTR)	NASDAQ:NMTR	9 Meters Biopharma Inc
2022/08/16	22 : 25	TipRanks	9 Meters Biopharma (NMTR) Gets a Buy from BMO Capital	NASDAQ:NMTR	9 Meters Biopharma Inc